Blue Heron Capital

Partnership is the work. At Blue Heron Capital, we don’t just invest. We get involved. Our team and the OA Collaborative bring real operating experience founders can use from day one to help navigate complexity and build momentum. When the right partner shows up at the right moment, everything changes. Hear from Co-Founder Tom Benedetti. #blueheroncapital #growthequity #partnership

Proud to see Luke Buchanan recognized by OhioX as a Next25 honoree. Luke's leadership at Redi Health reflects exactly what we value in founders and operators - clarity of vision, a team-first mindset, and a deep commitment to improving the patient experience. Well deserved recognition.

This month, we’re excited to spotlight Luke Leininger as our OA Collaborative member feature. Luke brings more than two decades of experience across healthcare, technology, and global policy, building businesses that scale with purpose. From leading Digital Healthcare at Cisco, to co-founding Avizia and guiding it through global growth and acquisition, Luke has consistently operated at the intersection of innovation, execution, and impact. Most recently, he served as VP of Strategy & Business Development at Henry Schein One, where he also led a high-growth Dental Analytics business. Along the way, he’s advised organizations across sectors and continents, always with a sharp eye on what actually works in the real world. Luke embodies what the OA Collaborative is about: experienced operators who think clearly, move decisively, and help founders build better businesses, without the fluff. We’re proud to have Luke in the OA Collaborative and as part of the Blue Heron Capital community. #BusinessBoldly #OACollaborative #GrowthEquity

Clear-eyed perspective on where healthcare is headed. Appreciate Clay Ritchey’s 2026 predictions from Verato, particularly around identity, data integrity, and the growing importance of trust as healthcare systems scale and modernize. At Blue Heron Capital, we see these themes showing up consistently across our partnerships, and they’ll only become more critical in the years ahead. Read more here: https://lnkd.in/g4bcdvm2

𝐏𝐫𝐨𝐠𝐫𝐞𝐬𝐬 𝐥𝐢𝐤𝐞 𝐭𝐡𝐢𝐬 𝐝𝐨𝐞𝐬𝐧’𝐭 𝐡𝐚𝐩𝐩𝐞𝐧 𝐨𝐯𝐞𝐫𝐧𝐢𝐠𝐡𝐭. Congratulations to CSA Medical Inc. on submitting a PMA to the FDA for the RejuvenAir System following positive pivotal trial results. As Tom Benedetti put it: “A lot of work went into this. Congrats to the CSA Medical team on hitting an important milestone!” Read the full announcement via PR Newswire. https://lnkd.in/gxi8K92U  

Choosing the right investor is about more than capital. It’s about trust, mentorship, and the network that helps you grow. Christine Hawkins, CEO of ChartSpan Medical Technologies, shares what CEOs should look for when selecting the right partner.

Thrilled to share Redi Health's latest perspective on optimizing patient access and strengthening provider operations. Proud to partner with a team that’s advancing what’s possible in healthcare delivery. Explore insights from their Executive Roundtable paper here.

This month, we’re featuring Matt Marek, Chairman & CEO of Frello and a valued member of the BHC OA Collaborative. Matt is a builder at heart. Before leading Frello, a peer-to-peer lending marketplace giving people more control over how they borrow and invest, he founded and scaled Good Neighbor, one of Virginia’s largest mental health and disability services providers. Under his leadership, Good Neighbor became a nationally recognized model for integrated care and innovation, ultimately leading to its acquisition by Sevita Health. Matt’s experience spans healthcare, technology, and advising leaders at organizations like Adidas, charity: water, Google, and Starbucks. His operator mindset and design-led approach make him an incredible partner to the companies we back. We’re grateful to have Matt in the OA Collaborative, helping bold companies scale with discipline. #OACollaborative #BlueHeronCapital #GrowthEquity

𝐖𝐡𝐚𝐭 𝐝𝐨 𝐟𝐨𝐮𝐧𝐝𝐞𝐫𝐬 𝐫𝐞𝐚𝐥𝐥𝐲 𝐧𝐞𝐞𝐝 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞𝐢𝐫 𝐢𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬? Hear it directly from Luke Buchanan, CEO of Redi Health, in this quick clip. He breaks down why Blue Heron Capital stood out, and what real partnership looks like during diligence. #BlueHeronCapital #GrowthEquity #OACollaborative

A big congratulations to ShiftMed for ranking #224 on the 2025 Deloitte Technology Fast 500™ - their fourth consecutive year being recognized among North America’s fastest-growing tech companies. It’s inspiring to see continued momentum across our portfolio, and ShiftMed’s innovation in healthcare workforce management is a standout. Proud to support their mission and growth. Read more here: